Please Wait

Applying Filters...

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

naftifine hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 8 USDMF, 2 EU WC, 1 KDMF, 3 NDC API, 10 Listed Suppliers, $ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 10 FDA Orange Book, 6 Europe, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 1%, CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 2%, GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

4 DKSH, 6 Nanjing Well Pharmaceutical, 4 Actylis, 8 BASF, 1 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 2 Lubrizol Life Science Health, 1 Microlex e.U, 1 Nanjing Bold Chemical, 10 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

24 Topical, 22 Solubilizers, 10 Emulsifying Agents, 10 Thickeners and Stabilizers, 10 Parenteral, 8 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Film Formers & Plasticizers, 2 Direct Compression, 1 Granulation, 1 Lubricants & Glidants, 1 Co-Processed Excipients, 1 API Stability Enhancers, 1 Controlled & Modified Release

DIGITAL CONTENT

3 News #PharmaBuzz

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 7 Regulatory FDF Prices

MARKET PLACE

15 APIs

15 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Chongqing Huapont Pharmaceutical	China	CHONGQING HUAPONT PHARMACEUTICAL CO LTD	28735	NAFTIFINE HYDROCHLORIDE	2014-08-10	Active	II	N/A
28/03/2025	Erregierre SpA	Italy	ERREGIERRE SPA	14711	NAFTIFINE HYDROCHLORIDE USP	2000-02-15	Active	II	N/A

Contact us
to update this info

Naftifine Hydrochloride

naftifine hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

8 USDMF

2 EU WC

1 KDMF

3 NDC API

10 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers

10 FDA Orange Book

6 Europe

2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 1%

CREAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 2%

GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

4 DKSH

6 Nanjing Well Pharmaceutical

4 Actylis

8 BASF

1 Corel Pharma Chem

2 Finar

5 Gangwal Chemicals

2 Lubrizol Life Science Health

1 Microlex e.U

1 Nanjing Bold Chemical

10 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

24 Topical

22 Solubilizers

10 Emulsifying Agents

10 Thickeners and Stabilizers

10 Parenteral

8 Surfactant & Foaming Agents

5 Rheology Modifiers

4 Film Formers & Plasticizers

2 Direct Compression

1 Granulation

1 Lubricants & Glidants

1 Co-Processed Excipients

1 API Stability Enhancers

1 Controlled & Modified Release

DIGITAL CONTENT

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

7 Regulatory FDF Prices

MARKET PLACE

15 APIs

PATENTS & EXCLUSIVITIES

6 US Patents

REF. STANDARDS & IMPURITIES

1 USP

1 Others

Filters

CREAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons